An interdisciplinary multi-center research team led by the LKS Faculty of Medicine (HKUMed) and Faculty of Dentistry at the ...

Investigators trialed injection of an immune-stimulating substance (poly-ICLC) into the prostate gland using MRI-ultrasound fusion technology in patients scheduled to undergo radical prostatectomy.

Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in recognition of her research into how tumor microenvironments impact cancer ...

Study suggests that persistently activated ATF6α is a tumor driver, a potential stratification marker for immunotherapy response, and a therapeutic target for HCC.

Ovarian cancer standard of care has not advanced in over 30 years, but a new DNA-based immunotherapy could be a gamechanger, showing major survival gains in clinical trials.

DIMAPUR — A research team lead by Nagaland University (NU) along with leading national research institutions, have published ...

Researchers in Sweden have identified an unexpected biological mechanism that could influence future cancer treatments. Scientists in Sweden have uncovered an unexpected anti-cancer effect from a ...

The field of regulated cell death has undergone a transformative shift with the discovery of novel modalities beyond apoptosis, such as ferroptosis, which ...

Pancreatic cancer has long been one of medicine’s most unforgiving puzzles, killing most patients within a few years and ...